antiviral news
Press Releases in the global landscape
Oct 20, 2025
Safety and efficacy of different therapeutic regimens in Egyptian adults with moderate COVID-19 infection (EVEREST): a real-world retrospective study
This study seeks to disseminate insights from Egypt’s management of COVID-19 patients by evaluating the effectiveness and safety of various treatment regimens using combined repurposed antivirals.
Read More »
Oct 3, 2025
Bispecific inhibitor can combat a wide range of coronaviruses, including Paxlovid-resistant variants
A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid.
Read More »
Oct 2, 2025
Trial: Paxlovid retreatment after COVID rebound tied to faster drop in viral RNA but no clinical benefit
The authors call for more research to identify patient groups that could benefit from repeated treatment for COVID-19 after symptom and/or viral RNA rebound.
Read More »
Sep 29, 2025
Unvaccinated May Benefit Most From COVID-19 Antivirals
Use of remdesivir and/or nirmatrelvir/ritonavir in patients hospitalised for acute SARS-CoV-2 is tied to fewer deaths during the Omicron era, notably in unvaccinated patients without prior infection.
Read More »
Sep 16, 2025
Studies show mostly poor long-COVID protection for Paxlovid
A small protective effect was seen only in older adults.
Read More »
Sep 5, 2025
US Stockpiles Remdesivir, Leaving World Without Coronavirus Treatment
U.S. Secures Exclusive July Supply, Majority of August-September Remdesivir Production.
Read More »